Valuation: MedPacto, Inc.

Market Cap 92.54B 62.12M 54.31M 50.1M 46.06M 87.26M 5.98B 88.76M 598M 235M 2.92B 233M 228M 10.07B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 53.57B 35.96M 31.44M 29M 26.66M 50.51M 3.46B 51.38M 346M 136M 1.69B 135M 132M 5.83B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day-0.74%
1 week-4.59%
Current month-14.15%
1 month-21.97%
3 months-49.72%
6 months-58.65%
Current year-59.58%
1 week 2,610
Extreme 2610
2,990
1 month 2,610
Extreme 2610
3,660
Current year 2,610
Extreme 2610
7,980
1 year 2,610
Extreme 2610
8,650
3 years 2,610
Extreme 2610
17,240
5 years 2,610
Extreme 2610
71,500
10 years 2,610
Extreme 2610
134,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Corporate Officer/Principal 67 -
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 63 28/03/2024
Director/Board Member 74 28/03/2024
Date Insider Type Main position Quantity % Market Cap.
04/03/25Buy 10,500 0.0306%
04/03/25Buy

Chief Executive Officer

31,882 0.0930%
04/03/25Buy 7,000 0.0204%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-4.59%-32.92%-81.48% 62.64M
-1.39%-6.15%+56.05%+124.73% 54.49B
+3.13%+13.95%+64.21%+94.35% 55.93B
-0.27%-5.77%+6.75%+433.06% 23.87B
+1.76%-1.65%-16.86%-15.01% 22.86B
+1.47%+8.04%+47.21%-1.98% 20B
+1.94%+0.21%+39.31%-27.77% 17.48B
+10.00%-4.30%+208.33%+370.99% 15.39B
+0.47%+13.68%+51.94%+726.32% 15.19B
-0.39%-1.00%+26.08%+186.49% 14.02B
Average +1.60%+0.07%+45.01%+180.97% 23.93B
Weighted average by Cap. +1.46%+0.48%+51.87%+170.90%

Financials

2024 2025
Net sales - 3.9K 2.62 2.29 2.11 1.94 3.68 251.8 3.74 25.2 9.89 123.07 9.83 9.61 424.2
Net income -20.14B -13.52M -11.82M -10.9M -10.02M -18.99M -1.3B -19.32M -130M -51.08M -636M -50.77M -49.66M -2.19B -12.81B -8.6M -7.52M -6.94M -6.38M -12.08M -827M -12.29M -82.8M -32.49M -404M -32.29M -31.59M -1.39B
Net Debt -53.54B -35.94M -31.42M -28.98M -26.64M -50.48M -3.46B -51.35M -346M -136M -1.69B -135M -132M -5.83B -38.97B -26.16M -22.87M -21.1M -19.4M -36.75M -2.52B -37.38M -252M -98.84M -1.23B -98.24M -96.09M -4.24B
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
-
Date Price Change Volume
15/07/26 KRW 2,700.00 -0.74% 103,966
14/07/26 KRW 2,720.00 0.00% 171,946
13/07/26 KRW 2,720.00 -3.20% 135,750
10/07/26 KRW 2,810.00 +1.08% 166,440
09/07/26 KRW 2,780.00 -1.77% 205,811
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock